Swedish geneticist Svantee Paabo, whose work provided key insights into human evolution and and how humans spread around the planet by achieving "the seemingly impossible task" of cracking the genetic code of the Neanderthals was Monday announced...
Zydus Lifesciences said it has received the USFDA's final nod to market its generic version of Mirabegron extended-release tablets used to treat overactive bladder, with 180 days of shared generic drug exclusivity. The final approval granted by...
The Department-related Parliamentary Standing Committee on health and family welfare has recommended to the Central government to look at regulating the price of services such as radio therapy, under the provisions of the Essential Commodities Act...
The new pharma health trends and the use of latest technologies such as Artificial Intelligence, Augmented Reality, additive manufacturing & Virtual Reality, are indications of a significant paradigm shift in the healthcare industry.
Amylyx Pharmaceuticals Inc said the U.S. Food and Drug Administration approved its drug for slowing the progression of ALS, or amyotrophic lateral sclerosis, and potentially delaying death, sending shares of the company up nearly 14% in extended...
Drug maker Lupin said it has launched Sildenafil for Oral Suspension, indicated for the treatment of pulmonary arterial hypertension, in the US market. The firm said it has introduced the product after getting approval from the US Food...
IQVIA announced that Dr Reddy’s Laboratories has selected IQVIA Orchestrated Customer Engagement (OCE) platform as its core CRM solution for its entire field force in India...
Krsnaa Diagnostics, a leading player in the diagnostics space, announced its plans to launch 600 diagnostics centres across India...
Bayer announced the launch of vericiguat (Verquvo), a soluble guanylate cyclase (sGC) stimulator, in India. Vericiguat is indicated, along with guideline-based medical therapy, in adults with symptomatic chronic heart failure with reduced ejection...
Torrent Pharmaceuticals Limited (Torrent Pharma) has entered into definitive agreements to acquire 100% of Curatio Healthcare (I) Private Limited (Curatio) for Rs. 2,000 crore. The consideration includes Rs. 115 crore (on the date of signing) of ...
, CDSCO.jpg)
